Biofourmis Receives Significant Growth Investment from to Propel Company to Unicorn Status

Funding Rounds

Summary

Biofourmis Receives Significant Growth Investment from to Propel Company to Unicorn Status

$ Funding

$
Amount $300.0M Total raised
Date April 26, 2022 Announcement date
Investors McKinsey & Company Lead investors
Company http://www.biofourmis.com Funded company

Classifications

industries
Fintech & Banking
applications
Data Management

AskAI Classifications

Labels
Health Technology Digital Health SaaS

Linked Companies

Biofourmis
$50M to $100M